For Research Purposes Only

sexual-health

PT-141 for Low Libido

FDA approved for HSDD in women

How It Works

Activates melanocortin receptors in the brain involved in sexual arousal.

Research Evidence

FDA approved (Vyleesi) for HSDD in women. Clinical trials in both sexes.

Dosing Protocol

1-2mg subcutaneously 2-4 hours before activity. Max 8 doses per month.

Important Considerations

  • !Significant nausea initially
  • !Not for daily use
  • !BP concerns
  • !Consult healthcare provider before use
  • !Quality sourcing is critical

Frequently Asked Questions

Does PT-141 work for low libido?

FDA approved (Vyleesi) for HSDD in women. Clinical trials in both sexes. Research level: FDA approved for HSDD in women.

How does PT-141 help with low libido?

Activates melanocortin receptors in the brain involved in sexual arousal.

What is the PT-141 dosage for low libido?

1-2mg subcutaneously 2-4 hours before activity. Max 8 doses per month.

Is PT-141 safe for low libido?

Key considerations: Significant nausea initially. Not for daily use. BP concerns. Consult healthcare provider before use. Quality sourcing is critical. Always consult a healthcare provider.

How long until PT-141 works for low libido?

Results vary by individual and condition severity. Most users report initial effects within 2-4 weeks, with full benefits developing over 8-12 weeks of consistent use.

Learn More

Disclaimer: This information is for educational and research purposes only. PT-141 is FDA approved for specific indications - consult a doctor.